Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00597948 · ClinicalTrials.gov registry record · NA

Healthy Lifestyles for People With Intellectual Disabilities

A NA study of Developmental Disabilities and Mental Retardation, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Completed
Registry status
NA
Development phase
131
Enrollment target
1
Study location

NCT00597948: Completed NA study of Developmental Disabilities and Mental Retardation, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

NCT00597948 is a NA study of Developmental Disabilities and Mental Retardation that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 131 participants, above the 68-participant average among 4 other Developmental Disabilities trials with a reported enrollment target (93% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00597948, a NA study of Developmental Disabilities and Mental Retardation, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

COMPLETED
Registry status
NA
Development phase
131 participants
Enrollment target
1
Study location

Study Summary

Relatively few health promotion and disease prevention programs have included or targeted people with disabilities, and even fewer have focused on individuals with intellectual disabilities. The long-term objectives of the Healthy Lifestyles for People with Intellectual Disabilities Study (HLID) are to increase the health of persons with intellectual disabilities by establishing the efficacy of a health promotion program and promoting its adoption. The HLID Study is based in the Center on Community Accessibility (CCA) at Oregon Health \& Science University. The mission of CCA is to increase the health and health-related quality of life of persons with disabilities. A pilot study conducted by CCA has established the effectiveness of the Healthy Lifestyles (HL) intervention among a cross-disability population in increasing health behavior adoption. The specific aim of the HLID Study is to test the efficacy of the HL program specifically with adults with intellectual disabilities. The HLID Study uses a randomized control study design. The HL intervention will be administered to 75 adults and will compare results to those of an additional 75 adults who receive no intervention. Measurement will include anthropometric assessments to measure impacts on overweight and obesity, as well as self-report measures of healthy behaviors, health status, health care utilization, and secondary conditions. Results will be shared with research participants, presented through professional conferences and newsletters, and published in peer-reviewed journals with the assistance of community partners.

Interventions

  • BEHAVIORAL Healthy Lifestyles Curriculum

Study Locations (1)

Oregon

  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 131 participants
Start Date 2007-04
Est. Completion 2010-03
Phase NA

What the finished NCT00597948 record still lists

NCT00597948 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, above the 68-participant average among 4 other Developmental Disabilities trials with a reported enrollment target (93% higher).

The record links to 3 conditions, with Developmental Disabilities appearing as the primary indexed condition, and to 1 intervention - of which Healthy Lifestyles Curriculum is the first listed.

NCT00597948 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT00597948 about?

NCT00597948 is a clinical study titled "Healthy Lifestyles for People With Intellectual Disabilities". Relatively few health promotion and disease prevention programs have included or targeted people with disabilities, and even fewer have focused on individuals with intellectual disabilities. The long-term objectives of the Healthy Lifestyles for People with Intellectual Disabilities Study (HLID) ar...

What is the current status of trial NCT00597948?

This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2007-04. Estimated completion is 2010-03.

What conditions does trial NCT00597948 study?

This clinical trial studies the following conditions: Developmental Disabilities, Mental Retardation, Intellectual Disabilities.

What interventions are being tested in trial NCT00597948?

The interventions under investigation include: Healthy Lifestyles Curriculum (BEHAVIORAL).

Who is sponsoring clinical trial NCT00597948?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00597948 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Developmental Disabilities

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03051464 · 131 participants · Phase 2

    No Surgery Trial / Two Dose-escalation Strategies

  • NCT04301843 · 131 participants · Phase 2

    Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

  • NCT04748549 · 131 participants · NA

    Intraoperative VR for Older Patients Undergoing TKA

  • NCT05951179 · 131 participants · Phase 2

    Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00597948, the US trial registry maintained by the National Library of Medicine. NCT00597948 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.